FFAR2 and malignant colon neoplasm: The anti-inflammatory role is further supported by the findings that Gpr43 blocks inflammasomes [93] and deletion of the receptor in mice leads to dysbiosis in colonic microflora and increased susceptibility to colon cancer [102].